Foreign device companies can expect a big opportunity for expansion in Southeast Asia.
With the largest patient population in the world, the region has high growth potential over the next few years.
Within this large and growing market, some companies are capitalizing, while others are faltering.
As CVD rates rise, so does the demand for devices that improve heart function and blood flow.
The emerging Asian middle class will soon demand the same healthcare benefits and medical devices as those in Europe and North America.
You can never do enough due diligence.
Device companies can tap into a growing market that needs more cost effective healthcare services.
Consider taking a multi-pronged approach to this complex landscape.
The strong demand for telemedicine services presents significant opportunities.
Choosing the right CRO has a big impact on product registration and time to market.